Axcellerate Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Axcellerate Pharma General Information

Description

Provider of contract manufacturing and research services intended to serve the biopharmaceutical industry. The company specializes in deploying a combination of assets and operational capabilities to provide CMO/CRO services and also manufactures early cGMP clinical supplies of drug substances and sterile drug products for both large and small molecules.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 20 Kingsbridge Road
  • Piscataway, NJ 08854
  • United States
Primary Industry
BPO/Outsource Services
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Parent Company
Generic Specialties
Vertical(s)
Corporate Office
  • 20 Kingsbridge Road
  • Piscataway, NJ 08854
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axcellerate Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axcellerate Pharma‘s full profile, request access.

Request a free trial

Axcellerate Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Axcellerate Pharma‘s full profile, request access.

Request a free trial

Axcellerate Pharma FAQs

  • When was Axcellerate Pharma founded?

    Axcellerate Pharma was founded in 2013.

  • Where is Axcellerate Pharma headquartered?

    Axcellerate Pharma is headquartered in Piscataway, NJ.

  • What industry is Axcellerate Pharma in?

    Axcellerate Pharma’s primary industry is BPO/Outsource Services.

  • Is Axcellerate Pharma a private or public company?

    Axcellerate Pharma is a Private company.

  • What is Axcellerate Pharma’s current revenue?

    The current revenue for Axcellerate Pharma is .

  • Who are Axcellerate Pharma’s investors?

    AlfaGene Bioscience and TCG Lifesciences USA have invested in Axcellerate Pharma.

  • When was Axcellerate Pharma acquired?

    Axcellerate Pharma was acquired on 17-May-2016.

  • Who acquired Axcellerate Pharma?

    Axcellerate Pharma was acquired by Generic Specialties.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process